Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3699880012 | Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3699881011 | Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 15 milligram and reserpine 100 microgram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Hydralazine and hydrochlorothiazide and reserpine only product in oral dose form | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | chlorhydrate d'hydralazine (substance) | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Reserpine (substance) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Product containing hydrochlorothiazide (medicinal product) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Product containing hydralazine (medicinal product) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | Hydralazine (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Hydralazine hydrochloride + hydrochlorothiazide + reserpine | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | chlorhydrate d'hydralazine (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | Centrally acting hypotensive agent (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | Reserpine (substance) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Hydralazine-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | Reserpine (substance) | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Reserpine (substance) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value (attribute) | 0.1 (qualifier value) | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | chlorhydrate d'hydralazine (substance) | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | chlorhydrate d'hydralazine (substance) | true | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value (attribute) | 25 (qualifier value) | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Reserpine (substance) | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | chlorhydrate d'hydralazine (substance) | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value (attribute) | 25 (qualifier value) | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | a pour principe actif (attribut) | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has basis of strength substance (attribute) | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value (attribute) | 15 (qualifier value) | false | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Product containing hydrochlorothiazide and reserpine (medicinal product) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | chlorhydrate d'hydralazine (substance) | false | Inferred relationship | Some | 2 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Product containing rauwolfia alkaloid in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 3 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has precise active ingredient | Reserpine (substance) | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | est un(e) (attribut) | Hydralazine- and hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator value (attribute) | 100 | false | Inferred relationship | Some | 1 | |
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet | Has presentation strength numerator unit | microgram (qualifier value) | false | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)